Cai Peng, Li Jingjing, Chen Guiming, Peng Bing, Yu Liuyang, Zhao Bolin, Yu Yi
Department of Oncology, Jingmen No. 2 People's Hospital, Jingmen, Hubei 448000, P.R. China.
Department of Oncology, Wuhan Hankou Hospital, Wuhan, Hubei 430012, P.R. China.
Oncol Lett. 2020 Mar;19(3):1958-1966. doi: 10.3892/ol.2020.11248. Epub 2020 Jan 7.
Lung cancer causes over 1.6 million mortalities worldwide annually. MicroRNAs (miRs) are involved in various types of cancer-associated processes. The present study investigated the possible mechanism of miR-107 in the development of lung cancer in order to identify novel targets for clinical treatment. The expression levels of miR-107 and its putative target gene TP53 regulated inhibitor of apoptosis 1 (TRIAP1) were measured in lung cancer tumor tissues and non-tumor adjacent tissues. Subsequently, the association between TRIAP1 and miR-107 was investigated using a dual-luciferase reporter assay. Following transfection, the effects of miR-107 and TRIAP1 on the proliferation and apoptosis of lung cancer cell lines were investigated using Cell Counting Kit-8 and flow cytometry assays, respectively. Furthermore, the regulatory effect of miR-107 on the expression levels of TRIAP1 and associated proteins was analyzed using a western blot assay. The results revealed lower expression levels of miR-107 and higher expression levels of TRIAP1 in lung cancer tumor tissues compared with non-tumor adjacent tissues. The dual-luciferase reporter assay demonstrated that TRIAP1 is a target gene of miR-107. Additionally, the results revealed that overexpression of miR-107 resulted in a lower proliferation rate and higher apoptosis rate of A549 cells, compared with the negative control (NC) and control groups (P<0.01). The variation of cell proliferation and apoptosis induced by miR-107 mimics was reversed by co-transfection with pcDNA3.1-TRIAP1. Furthermore, the expression levels of cyclin D1 and proliferating cell nuclear antigen were markedly decreased in the miR-107 mimics group compared with the NC group (P<0.01). The expression levels of BCL2 associated X apoptosis regulator, tumor protein p53 and caspase 3 were upregulated and the expression levels of TRIAP1 and BCL2 apoptosis regulator were significantly reduced in the miR-107 mimics group compared with the NC group (P<0.01). The results of the present study suggested that miR-107 regulates lung cancer cell proliferation and apoptosis by targeting TRIAP1.
肺癌每年在全球导致超过160万人死亡。微小RNA(miRs)参与各种癌症相关过程。本研究调查了miR-107在肺癌发生发展中的可能机制,以确定临床治疗的新靶点。检测了肺癌肿瘤组织和癌旁非肿瘤组织中miR-107及其假定靶基因TP53调控的凋亡抑制因子1(TRIAP1)的表达水平。随后,使用双荧光素酶报告基因检测法研究TRIAP1与miR-107之间的关系。转染后,分别使用细胞计数试剂盒-8和流式细胞术检测法研究miR-107和TRIAP1对肺癌细胞系增殖和凋亡的影响。此外,使用蛋白质印迹法分析miR-107对TRIAP1及相关蛋白表达水平的调控作用。结果显示,与癌旁非肿瘤组织相比,肺癌肿瘤组织中miR-107表达水平较低,TRIAP1表达水平较高。双荧光素酶报告基因检测表明TRIAP1是miR-107的靶基因。此外,结果显示,与阴性对照(NC)组和对照组相比,miR-107过表达导致A549细胞增殖率降低,凋亡率升高(P<0.01)。与pcDNA3.1-TRIAP1共转染可逆转miR-107模拟物诱导的细胞增殖和凋亡变化。此外,与NC组相比,miR-107模拟物组中细胞周期蛋白D1和增殖细胞核抗原的表达水平显著降低(P<0.01)。与NC组相比,miR-107模拟物组中BCL2相关X凋亡调节因子、肿瘤蛋白p53和半胱天冬酶3的表达水平上调,TRIAP1和BCL2凋亡调节因子的表达水平显著降低(P<0.01)。本研究结果表明,miR-107通过靶向TRIAP1调节肺癌细胞的增殖和凋亡。